FealtySign in
Promise-keeping streak4 kept in a rowguidance & buyback

CHURCH & DWIGHT CO INC /DE/

(CHD)

CIK 313927 · SEC filings only

Not yet gradedBuyback record
harness minimum not met
company entity
3 resolved promises

Not enough resolved promises to grade

3 of the 4 resolved buyback promises needed to publish a reliability grade. Here's what we're tracking — we never show a grade we can't back with receipts.

Resolved promises

Pro

Full say-do history

Free scorecards show the 12 most recent resolved buyback promises. See the complete multi-year record with Pro.

See Pro →

Credibility timeline

KEPT · Feb 21, 2019KEPT · Feb 18, 2020PARTIAL · Feb 15, 2024
20192024
Timeline as a list
  • Feb 21, 2019KEPTThe Board of Directors has authorized a new program under which up to $500 million of the Company's common stock may be repurchased in the future
  • Feb 18, 2020KEPTup to $500 million of the Company's common stock may be repurchased
  • Feb 15, 2024PARTIALthe Board of Directors authorized a new stock repurchase program under which up to $1 billion of the Company's common stock may be repurchased
3 resolved buyback promises · resolver resolver-v3 · score score-v1. Every verdict links to its source filing. Full methodology →
B+Guidance record
grade
company entity
25 resolved promises

Sector median (Industrial Applications and Services): B+ across 28 graded companies

Resolved promises

Pro

Full say-do history

Free scorecards show the 12 most recent resolved guidance promises. See the complete multi-year record with Pro.

See Pro →

Guidance by basis

42 of 67 guidance figures that were graded or dropped for basis could not be graded on the same basis (63%). Guidance marked “not judged” is in neither number.

Guidance typeSaidGradedDroppedOther
Revenue · non-GAAPcannot be graded4031
Revenue · basis not stated5024026
EPS · GAAP1100
EPS · non-GAAPcannot be graded4702423
EPS · basis not statedcannot be graded2601511

Said counts every revenue and EPS guidance figure on record. Dropped counts figures whose period was reported but which have no comparable GAAP actual in SEC XBRL. Other covers open, superseded, withdrawn and otherwise unresolved figures. The coverage note below counts every figure shown but not graded, including figures whose period has not been reported, so it can be larger.

How the site-wide rate is measured

Compare across companies

Guidance shown, not graded (82)

We show what was said — with its source filing — but never score it. The line under each statement says why.

  1. eps guidance fy · May 1, 2026
    Our Adjusted EPS expectation for 2026 remains at 5% to 8% growth
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  2. eps guidance fy · May 1, 2026
    We continue to expect full-year reported EPS to increase approximately 18% to 22%
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  3. eps guidance q · May 1, 2026
    expected Adjusted EPS of $0.88 per share for the quarter
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  4. eps guidance fy · Oct 31, 2025
    We expect full year Adjusted EPS growth for 2025 of approximately $3.49
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  5. eps guidance q · Oct 31, 2025
    we expect Adjusted EPS of approximately $0.83 per share
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  6. revenue guidance q · Oct 31, 2025
    organic sales growth of approximately 1.5%
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  7. revenue guidance fy · Oct 31, 2025
    We remain on track to deliver 2025 organic sales growth of approximately 1%
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  8. eps guidance fy · Aug 1, 2025
    We continue to expect full year Adjusted EPS growth for 2025 of 0 to 2%
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  9. eps guidance q · Aug 1, 2025
    we expect Adjusted EPS of $0.72 per share
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  10. eps guidance q · May 1, 2025
    we expect Adjusted EPS of $0.85 per share
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  11. eps guidance fy · May 1, 2025
    We now expect full year adjusted EPS growth for 2025 of 0% to 2%
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  12. revenue guidance fy · May 1, 2025
    We now expect organic sales growth of approximately 0% to 2%
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  13. revenue guidance q · May 1, 2025
    For Q2, we expect organic sales of approximately -2% to Flat
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  14. eps guidance fy · Jan 31, 2025
    Our Adjusted EPS expectation for 2025 is 7% to 8% growth
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  15. eps guidance q · Jan 31, 2025
    we expect Adjusted EPS of $0.90 per share
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  16. eps guidance fy · Jan 31, 2025
    $ 3.63 to 3.67
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  17. eps guidance q · Nov 1, 2024
    we expect reported EPS of $0.75
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  18. eps guidance fy · Nov 1, 2024
    We continue to expect full year adjusted EPS growth to be approximately 8%
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  19. eps guidance q · Nov 1, 2024
    Adjusted EPS of $0.76 per share
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  20. eps guidance q · May 2, 2024
    Adjusted EPS of $0.83 per share
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  21. eps guidance fy · May 2, 2024
    Our full year reported EPS growth is expected to be approximately +9.5-10.5%
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  22. eps guidance q · May 2, 2024
    we expect reported EPS of $0.81
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  23. eps guidance fy · May 2, 2024
    our Adjusted EPS growth expectation is now 8-9%
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  24. eps guidance fy · Feb 2, 2024
    Our Adjusted EPS expectation for 2024 is 7-9% growth
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  25. eps guidance q · Feb 2, 2024
    we expect Adjusted EPS of $0.85 per share
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  26. eps guidance q · Nov 3, 2023
    we expect Reported EPS of $0.60
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  27. eps guidance q · Nov 3, 2023
    Adjusted EPS of $0.63
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  28. eps guidance fy · Nov 3, 2023
    We continue to expect Reported EPS to be $3.03
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  29. eps guidance fy · Nov 3, 2023
    Adjusted EPS to be $3.15
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  30. eps guidance q · Jul 28, 2023
    Adjusted EPS of $0.66
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  31. eps guidance q · Jul 28, 2023
    we expect Reported EPS of $0.63
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  32. eps guidance fy · Jul 28, 2023
    Adjusted EPS to be $3.15
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  33. eps guidance fy · Jul 28, 2023
    We now expect Reported EPS to be $3.03
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  34. eps guidance q · Apr 27, 2023
    we expect Adjusted EPS of $0.78
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  35. eps guidance fy · Apr 27, 2023
    Diluted Earnings Per Share - Reported $ 2.91 to 2.97
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  36. eps guidance q · Apr 27, 2023
    Reported EPS is expected to be $0.75
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  37. eps guidance fy · Apr 27, 2023
    Diluted Earnings Per Share - Adjusted (non-GAAP) $ 3.03 to 3.09
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  38. eps guidance fy · Feb 3, 2023
    Our Adjusted EPS expectation for 2023 is 0-4% growth.
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  39. eps guidance q · Feb 3, 2023
    we expect Adjusted EPS of $0.75
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  40. eps guidance fy · Oct 28, 2022
    We now expect adjusted EPS to be in the range of $2.93-$2.97
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  41. eps guidance q · Oct 28, 2022
    We expect adjusted EPS of $0.58-$0.62
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  42. eps guidance fy · Apr 28, 2022
    we now expect EPS to be at 4%
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  43. eps guidance q · Apr 28, 2022
    we expect EPS of $0.70 per share
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  44. eps guidance q · Oct 29, 2021
    Adjusted EPS is expected to be $0.61 per share
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  45. eps guidance fy · Oct 29, 2021
    We expect full year 2021 adjusted EPS growth of 6%
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  46. eps guidance q · Apr 29, 2021
    Adjusted EPS is expected to be $0.69 per share
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  47. eps guidance fy · Apr 29, 2021
    We continue to expect 2021 to be another strong year with adjusted EPS of $3.00 to $3.06
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  48. eps guidance q · Oct 29, 2020
    we expect Q4 EPS to be $0.50-$0.52 per share excluding the acquisition earn-out adjustment
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  49. eps guidance fy · Oct 29, 2020
    we now expect adjusted EPS growth to be $2.79 to $2.81
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  50. eps guidance fy · Jul 31, 2020
    Adjusted EPS growth is expected to be 13%
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  51. eps guidance fy · Jan 31, 2020
    We expect 2020 to be another strong year with adjusted EPS of $2.64 to $2.69
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  52. eps guidance q · Jan 31, 2020
    adjusted EPS to be $0.73 per share
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  53. revenue guidance fy · Jan 31, 2020
    organic sales growth to be approximately 3.5%
    Not judged — the company guided on a basis or for a measure that the reported figure we hold does not match.Filing ↗
  54. revenue guidance q · Jan 31, 2020
    organic sales growth of approximately 3.0%
    Not judged — the company guided on a basis or for a measure that the reported figure we hold does not match.Filing ↗
  55. eps guidance q · Jul 31, 2019
    We expect adjusted EPS to be $0.60 per share
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  56. eps guidance fy · Jul 31, 2019
    We expect to achieve $2.47 per share
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  57. eps guidance fy · May 2, 2019
    We continue to expect 2019 adjusted EPS of $2.43 to $2.47
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  58. eps guidance q · May 2, 2019
    We expect adjusted EPS to be $0.52 per share
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  59. eps guidance fy · Feb 5, 2019
    We expect 2019 to be another strong year with EPS of $2.43 to $2.47
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  60. eps guidance q · Feb 5, 2019
    For Q1, we expect reported and organic sales growth of approximately 3.5% to 4% and EPS to be $0.66 per share
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  61. eps guidance fy · Nov 1, 2018
    Our 2018 EPS outlook is $2.27
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  62. eps guidance q · Nov 1, 2018
    We expect EPS to be $0.57 per share
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  63. revenue guidance fy · Nov 1, 2018
    organic sales growth to be approximately 4%
    Not judged — the company guided on a basis or for a measure that the reported figure we hold does not match.Filing ↗
  64. eps guidance q · May 3, 2018
    We expect EPS to approximate $0.46 per share
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  65. eps guidance fy · May 3, 2018
    2018 EPS Outlook: $2.24 to $2.28
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  66. eps guidance fy · Nov 2, 2017
    EPS is expected to be $1.82 per share
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  67. eps guidance fy · Nov 2, 2017
    we expect to achieve $1.92 per share
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  68. eps guidance q · Nov 2, 2017
    We expect EPS of $0.50 in the fourth quarter
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  69. eps guidance fy · May 4, 2017
    On a reported basis, EPS is expected to be $1.75 to $1.77 per share
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  70. eps guidance fy · May 4, 2017
    we expect to achieve 8.5% adjusted EPS growth or $1.92 per share
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  71. eps guidance q · May 4, 2017
    adjusted of $0.37 per share in the second quarter
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  72. eps guidance q · May 4, 2017
    We expect reported EPS of $0.21 to $0.23
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  73. eps guidance fy · Nov 3, 2016
    we expect to achieve high single digit EPS growth in 2017
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  74. eps guidance q · Nov 3, 2016
    EPS is expected to be $0.42
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  75. eps guidance fy · Nov 3, 2016
    We are tightening our EPS growth at the lower end of our previous range of 14-15% reported and 8-9% adjusted to 14% and 8%
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  76. eps guidance q · Aug 4, 2016
    Reported EPS is expected to be $0.92
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  77. eps guidance fy · Aug 4, 2016
    We now expect 14 to 15% reported and 8 to 9% adjusted EPS growth
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  78. eps guidance fy · Feb 2, 2016
    We expect to achieve 7 to 9% adjusted EPS growth.
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  79. eps guidance q · Feb 2, 2016
    earnings per share of $0.83
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  80. revenue guidance fy · Feb 2, 2016
    We expect organic sales growth of approximately 3%
    Not judged — the company guided on a basis or for a measure that the reported figure we hold does not match.Filing ↗
  81. revenue guidance q · Feb 2, 2016
    For the first quarter, we expect organic sales growth of approximately 2-3%
    Not judged — the company guided on a basis or for a measure that the reported figure we hold does not match.Filing ↗
  82. eps guidance q · Feb 2, 2016
    On an adjusted basis, EPS is expected to be $0.85
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗

Open promises (5) · 16 superseded

Open · revenue guidance fy

We now expect reported and organic sales growth at the lower end of our 3-4% range for the total Company

unresolved — no outcome on filereceipt (opens in a new tab)
Open · revenue guidance q

expect reported and organic sales growth of approximately 1-2%

unresolved — no outcome on filereceipt (opens in a new tab)
Open · revenue guidance q

we expect reported sales growth of approximately 12%

unresolved — no outcome on file$12.0000receipt (opens in a new tab)
Open · revenue guidance fy

We expect reported sales growth of approximately 7%

unresolved — no outcome on file$7.0000receipt (opens in a new tab)
Open · revenue guidance fy

We continue to expect reported sales to decline approximately 1.5% to 0.5%

resolves in ~155 daysreceipt (opens in a new tab)
Superseded · revenue guidance fy

We expect 2025 reported sales growth of approximately 0 to 2%

revised by a later guidancereceipt (opens in a new tab)
Superseded · revenue guidance fy

We now expect full year 2019 reported sales growth of approximately 5-6%

revised by a later guidancereceipt (opens in a new tab)
Superseded · revenue guidance fy

We now expect full year 2023 reported sales growth to be approximately 6-7%

revised by a later guidancereceipt (opens in a new tab)
Superseded · revenue guidance fy

We now expect full year 2021 reported sales growth to be 5-6%

revised by a later guidancereceipt (opens in a new tab)
Superseded · revenue guidance fy

We now expect full year 2023 reported sales growth to be approximately 8%

revised by a later guidance$8.0000receipt (opens in a new tab)
Superseded · revenue guidance fy

We continue to expect reported and organic sales growth of approximately 3-4%

revised by a later guidancereceipt (opens in a new tab)
Superseded · revenue guidance fy

We now expect approximately 9-10% full year 2020 sales growth

revised by a later guidancereceipt (opens in a new tab)
Superseded · revenue guidance fy

We now expect sales growth to be 9%

revised by a later guidancereceipt (opens in a new tab)
Superseded · revenue guidance fy

In 2025 we expect reported sales growth of approximately of 2.5% to 3.5%

revised by a later guidancereceipt (opens in a new tab)
Superseded · revenue guidance fy

We expect full year 2019 sales growth to be approximately 3.5%

revised by a later guidancereceipt (opens in a new tab)
Superseded · revenue guidance fy

We continue to expect full year 2024 reported and organic sales growth to be approximately 4 to 5%

revised by a later guidancereceipt (opens in a new tab)
Superseded · revenue guidance fy

We continue to expect full year 2022 reported sales growth to be approximately 5% to 8%

revised by a later guidancereceipt (opens in a new tab)
Superseded · revenue guidance fy

We expect reported and organic sales growth of approximately 3%

revised by a later guidancereceipt (opens in a new tab)
Superseded · revenue guidance fy

In 2024 we expect full year reported and organic sales growth to be approximately 4-5%

revised by a later guidancereceipt (opens in a new tab)
Superseded · revenue guidance fy

In 2023, we expect full year reported sales growth to be approximately 5-7%

revised by a later guidancereceipt (opens in a new tab)
Superseded · revenue guidance fy

We expect full year 2020 reported sales growth to be approximately 6.5%

revised by a later guidance$6.5000receipt (opens in a new tab)

Credibility timeline

IN LINE · Feb 16, 2023ABOVE · Feb 16, 2023ABOVE · Apr 27, 2023ABOVE · Feb 15, 2024IN LINE · Feb 15, 2024IN LINE · Feb 13, 2025ABOVE · Feb 13, 2025BELOW · May 1, 2025ABOVE · Oct 31, 2025IN LINE · Feb 12, 2026IN LINE · Feb 12, 2026ABOVE · Jul 31, 2026
20232026
Timeline as a list
  • Feb 16, 2023IN LINEWe continue to expect full year 2022 reported sales growth to be approximately 3%
  • Feb 16, 2023ABOVEin Q4, we expect reported sales growth of approximately 2%
  • Apr 27, 2023ABOVEFor Q1, we expect reported sales growth of approximately 4%
  • Feb 15, 2024ABOVEFor Q4, we expect reported sales growth of approximately 5%
  • Feb 15, 2024IN LINEWe now expect full year 2023 reported sales growth to be approximately 9%
  • Feb 13, 2025IN LINEWe continue to expect full year reported sales to be approximately 3.5%
  • Feb 13, 2025ABOVEFor Q4, we expect reported sales growth of approximately 1.5% to 2.5%
  • May 1, 2025BELOWFor Q1, we expect reported sales growth of approximately 1%
  • Oct 31, 2025ABOVEFor Q3, we expect reported and organic sales growth of approximately 1 - 2%
  • Feb 12, 2026IN LINEWe now expect higher 2025 reported sales growth of approximately 1.5%
  • Feb 12, 2026IN LINEFor Q4, we expect reported sales growth of approximately 3.5%
  • Jul 31, 2026ABOVEwe expect a reported sales decline of approximately 1%
25 resolved guidance promises · 82 not graded (no comparable reported figure) · resolver resolver-v5 · score score-v1. Every verdict links to its source filing. Full methodology →